ADMA Biologics, Inc. (ADMA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 4.35B |
| Enterprise Value | 4.34B |
| P/E Ratio | 13.16 |
| PEG Ratio | -0.64 |
| Price/Sales Ratio | 4.13 |
| Price/Book Ratio | 5.49 |
| Enterprise/Revenue | 4.26 |
| Enterprise/EBITDA | 9.8 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.32 |
| Operating Margin | 0.41 |
| Return On Assets | 0.25 |
| Return On Equity | 0.39 |
| Revenue | 510.17M |
| Revenue/Share | 2.16 |
| Gross Profit | 292.77M |
| EBITDA | 197.86M |
| Net Income | 146.93M |
| Diluted EPS | 0.6 |
| Total Cash | 138.15M |
| Total Cash/Share | 0.59 |
| Total Debt | 204.41M |
| Total Debt/Equity | 0.52 |
| Current Ratio | 6.95 |
| Book Value Per Share | 1.65 |
| 52-Week Change | -51.39 |
| 52-Week High | 20.46 |
| 52-Week Low | 7.21 |
| Moving Average 50 Days | 8.65 |
| Moving Average 200 Days | 13.81 |
| Average Volume | 5.07M |
| Shares Outstanding | 231.77M |
| % Held by Institutions | 88.89 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |